J 2020

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

DE LUCA, G.; M. VERDOIA; M. CERCEK; L. O. JENSEN; M. VAVLUKIS et al.

Základní údaje

Originální název

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

Autoři

DE LUCA, G.; M. VERDOIA; M. CERCEK; L. O. JENSEN; M. VAVLUKIS; L. CALMAC; T. JOHNSON; G. R. FERRER; V. GANYUKOV; W. WOJAKOWSKI; T. KINNAIRD; C. VAN BIRGELEN; Y. COTTIN; A. IJSSELMUIDEN; B. TUCCILLO; F. VERSACI; K. J . ROYAARDS; J. TEN BERG; M. LAINE; M. DIRKSEN; M. SIVIGLIA; G. CASELLA; Petr KALA; J. L. D. GIL; A. BANNING; V. BECERRA; C. DE SIMONE; A. SANTUCCI; X. CARRILLO; A. SCOCCIA; G. AMOROSO; A. LUX; T. KOVARNIK; P. DAVLOUROS; J. MEHILLI; G. GABRIELLI; X. F. RIOS; N. BAKRACESKI; S. LEVESQUE; G. CIRRINCIONE; V. GUIDUCCI; M. KIDAWA; L. SPEDICATO; L. MARINUCCI; P. LUDMAN; F. ZILIO; G. GALASSO; E. FABRIS; M. MENICHELLI; A. GARCIA-TOUCHARD; S. MANZO; G. CAIAZZO; J. MOREU; J. S. FORES; L. DONAZZAN; L. VIGNALI; R. TELES; E. BENIT; P. AGOSTONI; F. B. OJEDA; H. LEHTOLA; S. CAMACHO-FREIERE; A. KRAAIJEVELD; Y. ANTTI; M. BOCCALATTE; P. DEHARO; I. L. MARTINEZ-LUENGAS; B. SCHELLER; D. ALEXOPOULOS; R. MORENO; E. KEDHI; G. UCCELLO; B. FAURIE; A. G. BARRIOS; F. S. DI UCCIO; B. WILBERT; P. SMITS; G. CORTESE; G. PARODI a D. DUDEK

Vydání

Journal of the American College of Cardiology, New York, Elsevier Science INC, 2020, 0735-1097

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 24.093

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/20:00117705

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

COVID-19; primary angioplasty; STEMI

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 12. 1. 2021 12:41, Mgr. Tereza Miškechová

Anotace

V originále

BACKGROUND The fear of contagion during the coronavirus disease-2019 (COVID-19) pandemic may have potentially refrained patients with ST-segment elevation myocardial infarction (STEMI) from accessing the emergency system, with subsequent impact on mortality. OBJECTIVES The ISACS-STEMI COVID-19 registry aims to estimate the true impact of the COVID-19 pandemic on the treatment and outcome of patients with STEMI treated by primary percutaneous coronary intervention (PPCI), with identification of "at-risk" patient cohorts for failure to present or delays to treatment. METHODS This retrospective registry was performed in European high-volume PPCI centers and assessed patients with STEMI treated with PPPCI in March/April 2019 and 2020. Main outcomes are the incidences of PPCI, delayed treatment, and in-hospital mortality. RESULTS A total of 6,609 patients underwent PPCI in 77 centers, located in 18 countries. In 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio: 0.811; 95% confidence interval: 0.78 to 0.84; p < 0.0001). The heterogeneity among centers was not related to the incidence of death due to COVID-19. A significant interaction was observed for patients with arterial hypertension, who were less frequently admitted in 2020 than in 2019. Furthermore, the pandemic was associated with a significant increase in door-to-balloon and total ischemia times, which may have contributed to the higher mortality during the pandemic. CONCLUSIONS The COVID-19 pandemic had significant impact on the treatment of patients with STEMI, with a 19% reduction in PPCI procedures, especially among patients suffering from hypertension, and a longer delay to treatment, which may have contributed to the increased mortality during the pandemic. (C) 2020 by the American College of Cardiology Foundation.